PIGA, ISABELLA
 Distribuzione geografica
Continente #
NA - Nord America 6.802
AS - Asia 4.739
EU - Europa 4.494
SA - Sud America 736
AF - Africa 73
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 16.855
Nazione #
US - Stati Uniti d'America 6.609
SG - Singapore 1.520
IT - Italia 1.372
CN - Cina 1.128
VN - Vietnam 852
HK - Hong Kong 741
DE - Germania 666
RU - Federazione Russa 628
BR - Brasile 599
IE - Irlanda 517
SE - Svezia 451
GB - Regno Unito 227
AT - Austria 128
CA - Canada 121
IN - India 100
UA - Ucraina 97
ID - Indonesia 86
FR - Francia 82
NL - Olanda 60
AR - Argentina 56
FI - Finlandia 55
KR - Corea 54
PL - Polonia 53
JP - Giappone 52
MX - Messico 46
ES - Italia 40
BD - Bangladesh 39
ZA - Sudafrica 37
DK - Danimarca 36
TR - Turchia 28
EC - Ecuador 24
IR - Iran 17
LT - Lituania 16
BE - Belgio 15
TW - Taiwan 15
PY - Paraguay 14
IQ - Iraq 13
CO - Colombia 11
CH - Svizzera 10
VE - Venezuela 10
AU - Australia 9
SA - Arabia Saudita 9
CZ - Repubblica Ceca 8
IL - Israele 8
PK - Pakistan 8
MA - Marocco 7
MY - Malesia 7
PE - Perù 7
TH - Thailandia 7
UY - Uruguay 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
KE - Kenya 6
CL - Cile 5
EG - Egitto 5
KZ - Kazakistan 5
OM - Oman 5
PH - Filippine 5
PT - Portogallo 5
AL - Albania 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
PA - Panama 4
RO - Romania 4
AZ - Azerbaigian 3
BG - Bulgaria 3
BO - Bolivia 3
CR - Costa Rica 3
HN - Honduras 3
JM - Giamaica 3
JO - Giordania 3
KW - Kuwait 3
LB - Libano 3
LV - Lettonia 3
NP - Nepal 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BY - Bielorussia 2
ET - Etiopia 2
GA - Gabon 2
HR - Croazia 2
NG - Nigeria 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BT - Bhutan 1
CG - Congo 1
CI - Costa d'Avorio 1
DM - Dominica 1
EE - Estonia 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
HU - Ungheria 1
IM - Isola di Man 1
Totale 16.843
Città #
Ann Arbor 1.300
Singapore 915
Hong Kong 729
Ashburn 661
Milan 565
Dublin 506
Frankfurt am Main 466
Chandler 458
Fairfield 350
Wilmington 311
New York 241
Ho Chi Minh City 222
Dearborn 208
Dallas 207
Santa Clara 200
Hanoi 199
Beijing 163
Los Angeles 162
Woodbridge 157
Seattle 145
Cambridge 138
Houston 135
Princeton 135
Hefei 126
Shanghai 117
Dong Ket 116
Vienna 86
Nanjing 72
São Paulo 67
Jakarta 63
Moscow 63
The Dalles 54
Kent 48
Munich 48
Seoul 48
Jacksonville 46
Buffalo 43
Chicago 42
Nuremberg 40
London 39
Montreal 38
Tokyo 38
Warsaw 37
Brooklyn 35
Denver 34
Toronto 32
Guangzhou 31
Lawrence 28
Nanchang 28
Altamura 26
Cagliari 26
Madison 26
Orem 26
Caronno Pertusella 25
Changsha 25
Helsinki 25
Poplar 25
Shenyang 25
Fremont 24
Florence 22
Hải Dương 22
Ha Long 21
Lissone 21
Ottawa 21
Chennai 20
Da Nang 20
Hebei 20
Zhengzhou 20
Rome 19
San Diego 19
Tianjin 19
Jinan 18
Andover 17
Cinisello Balsamo 17
Haiphong 17
Pavia 17
Rio de Janeiro 17
Stockholm 17
Atlanta 16
Amsterdam 15
Belo Horizonte 15
Council Bluffs 15
Phoenix 15
Quận Bình Thạnh 15
Turku 15
Falls Church 14
Mexico City 14
Ningbo 14
Salt Lake City 14
San Francisco 14
Austin 13
Brussels 13
Johannesburg 13
Lappeenranta 13
Manchester 13
Romola 13
Boston 12
Brasília 12
Pune 12
Jiaxing 11
Totale 10.910
Nome #
Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging 542
Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma 484
In-Depth mapping of the urinary N-glycoproteome: Distinct signatures of ccRCC-related progression 468
Cytological Cytospin Preparation for the Spatial Proteomics Analysis of Thyroid Nodules Using MALDI-MSI 431
Antigen Retrieval and Its Effect on the MALDI-MSI of Lipids in Formalin-Fixed Paraffin-Embedded Tissue 384
Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades 379
Feasibility Study for the MALDI-MSI Analysis of Thyroid Fine Needle Aspiration Biopsies: Evaluating the Morphological and Proteomic Stability Over Time 353
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy 345
TdT expression in germ cell tumours: a possible immunohistochemical cross-reaction and diagnostic pitfall 329
Analysis of Hashimoto's thyroiditis on fine needle aspiration samples by MALDI-Imaging 325
Ex vivo thyroid fine needle aspirations as an alternative for MALDI-MSI proteomic investigation: intra-patient comparison 317
Matrix-assisted laser desorption/ionisation mass spectrometry imaging in the study of gastric cancer: A mini review 316
MALDI-MSI as a Complementary Diagnostic Tool in Cytopathology: A Pilot Study for the Characterization of Thyroid Nodules 313
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 309
Detecting Proteomic Indicators to Distinguish Diabetic Nephropathy from Hypertensive Nephrosclerosis by Integrating Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging with High-Mass Accuracy Mass Spectrometry 305
The management of haemoglobin interference for the MALDI-MSI proteomics analysis of thyroid fine needle aspiration biopsies 302
Molecular trait of follicular-patterned thyroid neoplasms defined by MALDI-imaging 279
Erratum: Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section (Journal of Proteome Research (2022) 21: 11 (2798−2809) DOI: 10.1021/acs.jproteome.2c00601) 277
The journey towards clinical adoption of MALDI-MS-based imaging proteomics: from current challenges to future expectations 261
A molecular imaging approach to individuate tumour infiltrating lymphocytes 248
Cytomolecular Classification of Thyroid Nodules Using Fine-Needle Washes Aspiration Biopsies 245
Lipidomic typing of colorectal cancer tissue containing tumour-infiltrating lymphocytes by MALDI mass spectrometry imaging 240
Unsupervised neural networks as a support tool for pathology diagnosis in MALDI-MSI experiments: A case study on thyroid biopsies 236
Spatial lipidomics of tumour-infiltrating lymphocytes for the typing of colorectal cancer by MALDI mass spectrometry imaging 227
Proteomics tools and mass spectometry imaging techiques for the molecular characterization of pancreas 219
Spatially Resolved Molecular Approaches for the Characterisation of Non-Invasive Follicular Tumours with Papillary-like Features (NIFTPs) 216
Update on: proteome analysis in thyroid pathology - part II: overview of technical and clinical enhancement of proteomic investigation of the thyroid lesions 210
Proteomic Fingerprint of Lung Fibrosis Progression and Response to Therapy in Bleomycin-Induced Mouse Model 209
Lights on HBME-1: the elusive biomarker in thyroid cancer pathology 208
Plasma Proteomic Variables Related to COVID-19 Severity: An Untargeted nLC-MS/MS Investigation 204
Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section 200
Serum Mass Spectrometry Proteomics and Protein Set Identification in Response to FOLFOX-4 in Drug-Resistant Ovarian Carcinoma 199
Advances in clinical proteomics for analysis of fine needle aspiration biopsies: evaluating proteomics stability in preservative solutions 196
Novel frontiers in diagnostic pathology: MALDI-MSI of thyroid fine needle aspiration biopsies 196
Putative salivary biomarkers useful to differentiate patients with fibromyalgia 193
DIA-PASEF mass spectrometry as a tailored proteomic approach to explore Idiopathic Membranous Nephropathy 192
Progress in clinical applications for the proteomics MALDI Imaging analysis of thyroid fine needle aspiration biopsies 191
Towards the Definition of the Molecular Hallmarks of Idiopathic Membranous Nephropathy in Serum Proteome: A DIA-PASEF Approach 189
Generation of a spectral library for DIA proteomics analysis and application to serum samples using TIMS-TOF MS/MS 182
Mapping the distribution of bioactive compounds and aroma/flavour precursors in green coffee beans with an integrated mass spectrometry-based approach 180
Ultra-high resolution MALDI-FTICR-MSI analysis of intact proteins in mouse and human pancreas tissue 179
Progress in clinical applications for the MALDI-imaging analysis of thyroid fine needle aspiration biopsies: evaluation of proteomic stability in preservative solutions 171
Total and synaptoproteomic changes underlying response/non-response to the rapid antidepressant effect of ketamine in the hippocampus of a preclinical model of depression. 170
The management of haemoglobin interference for the MALDI-MSI analysis of in-vivo thyroid biopsies 159
Glucagon-like peptide 1 protects INS-1E mitochondria against palmitate-mediated beta-cell dysfunction: A proteomic study 158
The evolving landscape of diagnostic pathology: a step towards the integration of MALDI-MSI for the routine diagnosis of thyroid fine needle aspiration biopsies 158
Pathology Laboratory Archives: Conservation Quality of Nucleic Acids and Proteins for NSCLC Molecular Testing 157
Progress in clinical applications for the MALDI-Imaging analysis of thyroid biopsies: evaluation of proteomic stability in preservative solutions 156
New insights in lipids MALDI MS imaging in FFPE tissue: Antigen retrieval and its effect on positive ion species 151
6-Aza-2-Thiothymine as an Alternative Matrix for Spatial Proteomics with MALDI-MSI 149
Influence of sampling on the determination of warfarin and warfarin alcohols in oral fluid 145
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 145
Ultra-high resolution MALDI-FTICR-MSI analysis of intact proteins in mouse and human pancreas tissue 144
MALDI-MS imaging in glomerular kidney diseases: from diagnostics to precision medicine? 144
MALDI-MSI as complementary tool in the characterization of thyroid nodules: novelties and challenges in the evolving landscape of diagnostic pathology 144
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 142
Paving the path toward multi-omics approaches in the diagnostic challenges faced in thyroid pathology 135
Determination of total and unbound warfarin and warfarin alcohols in human plasma by high performance liquid chromatography with fluorescence detection 135
C0513: A Non-Invasive Approach for Monitoring Patients Undergoing Anticoagulant Therapy 135
Recent advances in MALDI mass spectrometry imaging: a cutting edge tool for the diagnosis of thyroid nodules 135
Exploring 6-aza-2-Thiothymine as a MALDI-MSI Matrix for Spatial Lipidomics of Formalin-Fixed Paraffin-Embedded Clinical Samples 133
Data analysis optimisation of a DIA-PASEF mass spectrometry approach for the study of idiopathic membranous nephropathy disease 133
Strumentazione, preparazione del campione, deposito matrice, impostazione e lancio esperimento 131
Towards a standardised protocol for proteomic analysis of thyroid fine-needle-aspiration biopsies by MALDI-MSI: Management of haemoglobin interference 127
High resolution MALDI-FTICR-MSI analysis of intact proteins in mouse pancreas tissue 119
Development of mass spectrometry imaging methods for the analysis of intact proteins in mouse pancreas tissues by MALDI-TOF-MS and MALDI-FTICR-MS 119
Tri-modal MALDI-MS imaging on the same tissue section: deeper molecular insights of disease 116
Tri-modal MALDI-MS imaging of lipids, N-Glycans, and proteins on a single tissue section 116
Determination of anticoagulant drugs and their metabolites in oral fluid: strategies for sample collection 115
High resolution MALDI-FTICR-MSI analysis of intact proteins in mouse pancreas tissue 114
Comparative proteomics of native tuscany cultivars of olea europaea: a preliminary study 113
Determination of Warfarin and Warfarin alcohols in oral fluid and plasma samples for monitoring patients undergoing anticoagulant therapy 112
Towards lipid MALDI-MS imaging in FFPE tissue: antigen retrieval and its effect on positive ion species 112
Influence of sampling on the measured concentration of Warfarin and Warfarin alcohols in oral fluid 111
Determination of Warfarin and Warfarin alcohols in saliva and plasma by high performance liquid chromatography with fluorimetric detection 111
Tri-modal MALDI-MS Imaging: new frontiers in diagnostics 111
Delving deeper into the tissue proteome: improving cell-specificity with high spatial resolution MALDI-MS Imaging 111
Determination of anticoagulant drugs and their metabolites in oral fluid and plasma samples by HPLC-Fluorimetry 110
New frontiers in Pathology: MALDI-MS Imaging for diagnosis of thyroid fine needle aspiration biopsies 105
Elaborazione dei dati analitici: valutazione della qualità e costruzione di immagini molecolari 104
Does the urinary proteome reflect ccrcc stage and grade progression? 103
MALDI-MS Imaging Application in Thyroid FNA: Challenges and Perspectives 102
Glucagon-like peptide-1 protects INS-1E against palmitatemediated β-cell dysfunction: a proteomic study 101
Monitoring of warfarin therapy: Preliminary results from a longitudinal pilot study 101
New insights in MSI pathology: a molecular snapshot of thyroid cancer 100
Machine Learning Ensemble Algorithms for Classification of Thyroid Nodules Through Proteomics: Extending the Method of Shapley Values from Binary to Multi-Class Tasks 96
Advances in thyroglobulin measurement: exploring dried blood spot sampling and mass spectrometry for enhanced clinical utility 90
Strumentazione, preparazione del campione, deposito matrice, impostazione e lancio esperimento 86
Biomarker identification through spatial proteomics for the characterization of indeterminate thyroid nodules 83
Elaborazione dei dati analitici: valutazione della qualità e costruzione di immagini molecolari 80
Recent Advances in MALDI Mass Spectrometry Imaging: A Cutting-Edge Tool for the Diagnosis of Thyroid Nodules 54
Elaboration Pipeline for the Management of MALDI-MS Imaging Datasets 43
Well Begun Is Half Done: The Impact of Pre-Processing in MALDI Mass Spectrometry Imaging Analysis Applied to a Case Study of Thyroid Nodules 30
Totale 17.503
Categoria #
all - tutte 57.316
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.316


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.166 0 0 0 0 0 218 165 207 118 110 99 249
2021/20221.078 96 98 59 128 60 91 9 60 44 95 115 223
2022/20231.981 219 504 220 162 96 271 21 129 165 34 88 72
2023/20241.632 52 53 78 114 165 447 325 46 130 26 58 138
2024/20253.411 152 277 226 165 278 140 202 95 412 599 308 557
2025/20265.213 1.190 632 757 1.188 1.048 398 0 0 0 0 0 0
Totale 17.503